This review of pharmacotherapy for frontotemporal lobar degeneration describes the chemical rationale for agents used and reports observed responses to psychotropic medications. Paroxetine addressed anxiety and repetitive, ritualistic behaviors. Depression was resistant to treatment. Valproic acid and quetiapine calmed agitated subjects without exacerbating Parkinsonism. Donepezil has not emerged as a beneficial medication for this group of subjects. Behavioral disturbances can be alleviated pharmacologically, but further research might determine guidelines for management of this non-Alzheimer's dementia syndrome that could decrease the frequency of adverse drug events.
Mendez MF, Chow T, Ringman J, et al.: Pedophilia and temporal lobe disturbances. J Neuropsychiatry Clin Neurosci. 2000; 12: 71-76.
2.
Mendez MF, Perryman KM, Miller BL, et al.: Compulsive behaviors as presenting symptoms of frontotemporal dementia. J Geriatr Psychiatry Neurol.1997; 10: 154-157.
3.
Mendez MF, Selwood A, Mastri AR, et al.: Pick's disease versus Alzheimer's disease: Comparison of clinical characteristics. Neurology. 1993; 43: 289-292.
4.
Levy M, Miller BL, Cummings JL, et al.: Alzheimer's disease and frontotemporal dementias: Behavioral distinctions. Arch Neurol.1996; 53: 687-690.
Chow TW, Miller BL, Boone K, et al.: Frontotemporal dementia classification and neuropsychiatry. Neurologist. 2002; 8: 263-269.
7.
Neary D, Snowden JS, Gustafson L, et al.: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-1554.
8.
Edwards-Lee T, Miller BL, Benson DF, et al.: The temporal variant of frontotemporal dementia. Brain. 1997; 120: 1027-1040.
9.
Gregory CA, Hodges JR: Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm.1996; 47: 103-123.
10.
Miller BL, Darby A, Benson DF, et al.: Aggressive, socially disruptive, and antisocial behavior associated with frontotemporal dementia. Br J Psychiatr.1997; 170: 150-155.
11.
Silverman DH, Small GW, Chang CY, et al.: Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA. 2001; 286: 2120-2127.
12.
Cummings JL, Mega M, Gray K, et al.: The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44: 2308-2314.
13.
Chouinard G, Saxena B, Belanger MC, et al.: A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder. J Affect Disord. 1999; 54: 39-48.
14.
Francis PT, Holmes C, Webster MT, et al.: Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia. 1993; 4: 72-79.
15.
Sparks DL, Markesbery WR: Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol.1991; 48: 796-799.
16.
Sjogren M, Minthon L, Passant U, et al.: Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging. 1998; 19: 379-384.
17.
Swartz R, Miller BL, Lesser IM, et al.: Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: A retrospective analysis. J Geriatr Psychiatry Neurol.1997; 10: 67-74.
18.
Frisoni GB, Pizzolato G, Bianchetti A, et al.: Single photon emission computed tomography with [99Tc]-HMPAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: Preliminary results. Acta Neurologica Scand. 1994; 89: 199-203.
19.
Dunner DL: Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry. 1994; 55: 48-57.
20.
Magnuson TM, Roccaforte WH, Wengel SP, et al.: Medicationinduced dystonias in nine patients with dementia. J Neuropsychiatry Clin Neurosci. 2000; 12: 219-225.
21.
Mega MS, Dinov ID, Lee L, et al.: Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2000; 12: 209-218.
22.
Tanaka Y, Miyazaki M, Albert ML: Effects of increased cholinergic activity on naming in aphasia. Lancet. 1997; 350: 116-117.
23.
Urrutia L, Read M, Swartz R, et al.: Differentiation of Alzheimer's disease, frontotemporal dementia, and parkinsonian dementias. In Facts and Research in Gerontology, 1996: Alzheimer's Disease. New York: Springer, 1996, pp. 7-16.
24.
Pina Latorre M, Modrego P, et al.: Parkinsonism and Parkinson's disease associated with long-term administration of sertraline. J Clin Pharm Ther.2001; 26: 111-112.
